CSIMarket Company Name, Ticker, Competitors, else..
 
Cbdmd Inc   (NYSEAMER: YCBD)
Other Ticker:  
 
 
Price: $0.4096 $0.01 2.145%
Day's High: $0.43 Week Perf: -12.8 %
Day's Low: $ 0.39 30 Day Perf: -7.98 %
Volume (M): 44 52 Wk High: $ 1.73
Volume (M$): $ 18 52 Wk Avg: $0.65
Open: $0.40 52 Wk Low: $0.39



 Market Capitalization (Millions $) 1
 Shares Outstanding (Millions) 4
 Employees -
 Revenues (TTM) (Millions $) 21
 Net Income (TTM) (Millions $) -19
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 0

Cbdmd Inc
CBDmd Inc. is an innovative company that specializes in producing high-quality CBD products. They offer a wide range of products, including oils, capsules, topicals, and pet products, all made from organically grown hemp. The company prides itself on its commitment to transparency and quality, ensuring that every product is third-party tested for purity and potency. With a team of experienced scientists, CBDmd Inc. strives to provide customers with effective and safe CBD options for various health and wellness needs.


   Company Address: 2101 Westinghouse Blvd., Suite A Charlotte 28273 NC
   Company Phone Number: 445-3060   Stock Exchange / Ticker: NYSEAMER YCBD


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Cbdmd Inc

2. Financial Struggles Continue for Cbdmd Inc as Revenue Plummets in Q1 of 2024



Cbdmd Inc, a prominent player in the Personal & Household Products industry, reported a bleak financial performance for the first quarter of the fiscal year 2024. To the disappointment of investors, declining orders led to an increase in losses, with significant drops in both revenue and earnings per share.
For the January to March 31, 2024 period, Cbdmd Inc's loss per share rose to $-1.35 from $-1.74. This marked a concerning trend, indicating ongoing financial difficulties. Furthermore, the company's revenue drastically dropped by a staggering -29.864% to $4.38 million from $6.24 million recorded during the same period last year.
Cbdmd Inc

Cbdmd Inc Reveals Challenging First Quarter Results with Sharp Decline in Revenue2.

The financial results for the first quarter of 2024 for Cbdmd Inc raise some concerning points that may impact the company going forward. Losses have significantly increased to $-0.67 per share compared to $-0.08 a year ago, while the EPS has improved slightly from the previous financial reporting period. The revenue has also seen a considerable decline of -11.665% to $5.38 million from $6.09 million in the same period last year, with a sequential decrease of -5.872%.
This deterioration in revenue is in contrast to the Personal & Household Products industry as a whole, which saw a top-line gain during the same period. The net loss for the quarter improved slightly to $-0.997 million from $-3.956 million in the comparable period a year ago. However, the level of inventories has declined, which could be indicative of future demand, with inventories dropping to $3.6 million compared to the previous quarter and the same period a year ago.
Cbdmd Inc

CBDMD Inc. Makes a Resilient Comeback: Bounces Back from Fourth Quarter Slump with -27.341% Revenue Decline

nYCBDs refers to the ticker symbol for Cbdmd Inc.
Interpreting the Financial Results of Cbdmd Inc.
Cbdmd Inc

Cbdmd Inc Faces Bleak Future as Share Prices Soar But Losses Skyrocket in Third Quarter of 2023



cbdMD Inc, a prominent player in the cannabidiol (CBD) industry, has witnessed a remarkable surge in its share prices over the past three months, accompanied by an astounding increase of 520.39% in the year 2023. However, financial data reveals a weak business performance, marked by rising losses and declining revenue. This article delves into the implications of these financial results on cbdMD Inc's future prospects.
Financial Performance Analysis:
In the financial period ending June 30, 2023, cbdMD Inc recorded a net loss per share of $-1.16, compared to $-0.55 in the previous year. Additionally, revenue plummeted by -28.786% to $6.12 million from $8.59 million. The second quarter witnessed a further decline in revenue to $6.12 million, while the Income per Share improved from $-1.74 per share.
Cbdmd Inc

YCBD Faces Significant Revenue Decline as Inventory Turnover Ratio Plummets in Q2 2023

Cbdmd Inc experiences a decrease in inventory turnover ratio in the second quarter of 2023, with it falling to 2.31. This decrease is not surprising, as the company continues to face headwinds that affect its supply chain. Additionally, the average inventory processing period in Mar 31 2023 quarter increased to 158 days from 146 days in the Dec 31 2022 quarter.
Compared to its peers in the Consumer Non Cyclical sector, Cbdmd Inc ranks lower, with 78 companies having a higher inventory turnover ratio. However, the company's rank has increased from the previous quarter, now at 1485.






Cbdmd Inc's Segments
Sales Channel, Directly to Consumer    76.11 % of total Revenue
Sales Channel, Through Intermediary    23.89 % of total Revenue





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com